Katikati man Roy Nugter’s plea for Keytruda, to help stay alive long enough to watch his son grow up
nzherald.co.nz/bay-of-plenty-times/news/katikati-man-roy-nugters-plea-keytruda-to-help-stay-alive-long-enough-to-watch-son-grow-up/TC52DHR3P5DETEUS3UWJVWP2QQ/
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return: An experimental mRNA cancer vaccine developed by Moderna Inc (MRNA.O) and Merck & Co (MRK ...
reuters.com/business/healthcare-pharmaceuticals/moderna-cancer-vaccine-with-mercks-keytruda-delays-return-deadly-skin-cancer-2023-04-16/
Merck Snags $10.8 Billion Buyout As Keytruda Declines Loom: Merck is acquiring Prometheus Bio in a well-timed $10.8 billion deal ahead of Keytruda's patent loss ...
investors.com/news/technology/rxdx-stock-merck-nabs-deal-as-keytruda-patent-expiration-looms/
Merck, Eisai to discontinue late-stage study for skin cancer: Merck & Co Inc (MRK.N) and Eisai Co Ltd (4523.T) said on Friday they were discontinuing a ...
reuters.com/business/healthcare-pharmaceuticals/merck-eisai-discontinue-late-stage-study-skin-cancer-2023-04-07/
Moderna Crumbles On The 'Longish' Road For Its Cancer Vaccine: Moderna stock crumbled Monday after updated results for its Merck-partnered cancer vaccine show a ...
investors.com/news/technology/moderna-stock-crumbles-on-longish-road-for-cancer-vaccine/
Moderna Stumbles Despite A Win For Its Cancer Vaccine: Moderna stock fell Monday after European regulators granted its Merck-partnered personalized cancer ...
investors.com/news/technology/moderna-stock-jumps-on-european-designation-for-cancer-vaccine/
Merck scraps third prostate cancer study as Keytruda therapy disappoints: Merck & Co (MRK.N) on Tuesday scrapped a late-stage trial of a combination therapy with ...
reuters.com/business/healthcare-pharmaceuticals/merck-discontinue-keytruda-combination-study-prostate-cancer-2023-02-28/
Could Merck's Next Keytruda-Like Drugs Top $10 Billion In Sales?: Two of Merck's new drugs could generate north of $10 billion in peak sales ...
investors.com/news/technology/merck-stock-keytruda-who-analysts-eye-two-heart-drugs/
Senator Warren urges U.S. patent office to scrutinize Merck's Keytruda: U.S. Senator Elizabeth Warren sent the nation's top patent regulator a letter urging ...
reuters.com/world/us/senator-warren-urges-us-patent-office-scrutinize-mercks-keytruda-2023-02-23/
Pfizer is expecting its covid windfall to end in 2023: The company projects revenue from covid products drop by as much as 64%
qz.com/pfizer-is-expecting-its-covid-windfall-to-end-in-2023-1850061387
Merck scraps Keytruda trial for prostate cancer after dismal interim data: Merck & Co Inc (MRK.N) said on Wednesday it was discontinuing a late-stage trial of ...
reuters.com/business/healthcare-pharmaceuticals/mercks-keytruda-extends-survival-bile-duct-cancer-patients-2023-01-25/
‘You can’t fathom it when you’re given an expiry date’: Northland woman’s melanoma journey
nzherald.co.nz/northern-advocate/news/you-cant-fathom-it-when-youre-given-an-expiry-date-northland-womans-melanoma-journey/G47ZM6I6ENC2ZEXBLJX3JZQN6A/
Moderna mRNA vaccine reduced risk of skin cancer relapse: research: Researchers found the combination of Moderna’s mRNA vaccine and Merck’s Keytruda in melanoma ...
thehill.com/policy/healthcare/3773428-moderna-mrna-vaccine-reduced-risk-of-skin-cancer-relapse-research/
Pharmac set to fund two sought-after lung cancer drugs, Keytruda and Tecentriq: Pharmac has reached provisional agreements with the markers of Keytruda and ...
rnz.co.nz/news/national/480884/pharmac-set-to-fund-two-sought-after-lung-cancer-drugs-keytruda-and-tecentriq
Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
reuters.com/business/healthcare-pharmaceuticals/merck-could-keep-its-patent-edge-by-shifting-keytruda-cancer-drug-simple-shot-2022-12-02/
Study: Moderna, Merck vaccines could cut melanoma's recurrence by 44 percent
theweek.com/speed-reads/1019251/study-moderna-merck-vaccines-could-cut-melanomas-recurrence-by-44-percent
New drug offers lifeline to 1,600 women with rare aggressive form of breast cancer
news.sky.com/story/new-drug-offers-lifeline-to-1-600-women-with-rare-aggressive-form-of-breast-cancer-12741026
Merck lifts full-year forecast as Keytruda sales soar: Merck & Co (MRK.N) on Thursday reported higher-than-expected third-quarter sales and profit on a jump in ...
reuters.com/business/healthcare-pharmaceuticals/merck-third-quarter-earnings-climb-lifts-full-year-outlook-2022-10-27/
Scientists Are Testing a Personalized Skin Cancer Vaccine - ExtremeTech: The vaccine combines two medical technologies: the mRNA vaccine and Keytruda ...
extremetech.com/extreme/340286-scientists-are-testing-a-personalized-skin-cancer-vaccine
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics